ADMA
insider transactionsADMA BIOLOGICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $468.3K.
Net shares · 365d
-6.7K
45.4K buy · 52.1K sell
Net value · 365d
-$345.5K
$468.3K in · $813.8K out
Sentiment · 365d
Net selling
37% buying · 63% selling
Open-market trades · 365d
10
45.4K buy · 52.1K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Director
$50.6K
6.4K sh · $7.91
Own +1%
-
Buy·P
Director
$100.1K
12.5K sh · $8.01
Own +2%
-
Buy·P
Director
$100.1K
12.5K sh · $8.01
Own +3%
-
Other·F
COO and SVP, Compliance
$185.5K
20.4K sh · $9.11
Own -4%
-
Other·G
Director
$0
30.0K sh
Own -22%
-
Exercise·M
Adam S Grossman KEY
President and CEO · 10b5-1
$0
15.0K sh
Own +2%
-
Sell·S
Adam S Grossman KEY
President and CEO · 10b5-1
$91.0K
6.0K sh · $15.16
Own -0%
-
Sell·S
Adam S Grossman KEY
President and CEO · 10b5-1
$227.4K
15.0K sh · $15.16
Own -1%
-
Exercise·M
Adam S Grossman KEY
President and CEO · 10b5-1
$81.0K
15.0K sh · $5.40
Own +1%
-
Exercise·M
Director
$0
30.0K sh
Own New
-
Exercise·M
Director
$109.8K
30.0K sh · $3.66
Own +28%
-
Exercise·M
COO and SVP, Compliance
$0
2.2K sh
Own +335%
-
Exercise·M
COO and SVP, Compliance
$0
1.5K sh
Own +218%
-
Exercise·M
COO and SVP, Compliance
$0
2.6K sh
Own +2117%
-
Exercise·M
COO and SVP, Compliance
$0
1.2K sh
Own New
-
Exercise·M
COO and SVP, Compliance
$0
2.5K sh
Own New
-
Sell·S
COO and SVP, Compliance
$157.8K
10.1K sh · $15.63
Own -2%
-
Exercise·M
COO and SVP, Compliance
$3.4K
2.2K sh · $1.55
Own +0%
-
Exercise·M
COO and SVP, Compliance
$3.6K
1.5K sh · $2.35
Own +0%
-
Exercise·M
COO and SVP, Compliance
$7.5K
2.6K sh · $2.83
Own +1%
-
Exercise·M
COO and SVP, Compliance
$5.4K
1.2K sh · $4.31
Own +0%
-
Exercise·M
COO and SVP, Compliance
$12.5K
2.5K sh · $5.00
Own +1%
-
Other·J
COO and SVP, Compliance
$0
91.3K sh
-
Other·F
COO and SVP, Compliance
$65.2K
4.2K sh · $15.39
Own -1%
-
Other·F
Adam S Grossman KEY
President and CEO
$454.2K
29.5K sh · $15.39
Own -1%
-
Buy·P
Director
$107.7K
7.0K sh · $15.39
Own +0%
-
Other·F
COO and SVP, Compliance
$154.8K
10.1K sh · $15.39
Own -2%
-
Other·F
Adam S Grossman KEY
President and CEO
$868.6K
56.4K sh · $15.39
Own -3%
-
Buy·P
Director
$109.7K
7.0K sh · $15.67
Own +0%
-
Other·F
Adam S Grossman KEY
President and CEO
$832.7K
54.9K sh · $15.18
Own -2%
-
Other·F
COO and SVP, Compliance
$133.2K
8.2K sh · $16.32
Own -1%
-
Other·F
Adam S Grossman KEY
President and CEO
$404.6K
24.8K sh · $16.32
Own -1%
-
Other·F
Brad L. Tade KEY
CFO and Treasurer
$105.7K
6.5K sh · $16.32
Own -3%
-
Exercise·M
Adam S Grossman KEY
President and CEO · 10b5-1
$0
15.0K sh
Own +2%
-
Sell·S
Adam S Grossman KEY
President and CEO · 10b5-1
$96.5K
6.0K sh · $16.08
Own -0%
-
Sell·S
Adam S Grossman KEY
President and CEO · 10b5-1
$241.2K
15.0K sh · $16.08
Own -1%
-
Exercise·M
Adam S Grossman KEY
President and CEO · 10b5-1
$81.0K
15.0K sh · $5.40
Own +1%
-
Grant·A
Director
$0
17.7K sh
Own New
-
Grant·A
Director
$0
10.7K sh
Own +2%
-
Grant·A
COO and SVP, Compliance
$0
144.2K sh
Own New
-
Grant·A
COO and SVP, Compliance
$0
91.6K sh
Own +19%
-
Grant·A
Adam S Grossman KEY
President and CEO
$0
444.7K sh
Own New
-
Grant·A
Adam S Grossman KEY
President and CEO
$0
282.5K sh
Own +14%
-
Grant·A
Director
$0
17.7K sh
Own New
-
Grant·A
Director
$0
10.7K sh
Own +4%
-
Grant·A
Director
$0
17.7K sh
Own New
-
Grant·A
Director
$0
10.7K sh
Own +31%
-
Grant·A
Director
$0
17.7K sh
Own New
-
Grant·A
Director
$0
10.7K sh
Own +98%
-
Grant·A
Director
$0
17.7K sh
Own New
-
Grant·A
Director
$0
10.7K sh
Own +11%
-
Grant·A
Director
$0
17.7K sh
Own New
-
Grant·A
Director
$0
10.7K sh
Own +12%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | Jerrold B Grossman | Buy P | 6.4K | $50.6K |
| May 12, 2026 | Jerrold B Grossman | Buy P | 12.5K | $100.1K |
| May 11, 2026 | Jerrold B Grossman | Buy P | 12.5K | $100.1K |
| Apr 1, 2026 | Kaitlin M. Kestenberg-Messina | Other F | 20.4K | $185.5K |
| Mar 17, 2026 | Lawrence P. Guiheen | Other G | 30.0K | $0 |
| Mar 16, 2026 | Adam S Grossman KEY 10b5-1 | Exercise M | 15.0K | $0 |
| Mar 16, 2026 | Adam S Grossman KEY 10b5-1 | Sell S | 6.0K | $91.0K |
| Mar 16, 2026 | Adam S Grossman KEY 10b5-1 | Sell S | 15.0K | $227.4K |
| Mar 16, 2026 | Adam S Grossman KEY 10b5-1 | Exercise M | 15.0K | $81.0K |
| Mar 13, 2026 | Lawrence P. Guiheen | Exercise M | 30.0K | $0 |
| Mar 13, 2026 | Lawrence P. Guiheen | Exercise M | 30.0K | $109.8K |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 2.2K | $0 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 1.5K | $0 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 2.6K | $0 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 1.2K | $0 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 2.5K | $0 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Sell S | 10.1K | $157.8K |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 2.2K | $3.4K |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 1.5K | $3.6K |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 2.6K | $7.5K |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 1.2K | $5.4K |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Exercise M | 2.5K | $12.5K |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina | Other J | 91.3K | $0 |
| Mar 7, 2026 | Kaitlin M. Kestenberg-Messina | Other F | 4.2K | $65.2K |
| Mar 7, 2026 | Adam S Grossman KEY | Other F | 29.5K | $454.2K |
| Mar 6, 2026 | Steve Elms | Buy P | 7.0K | $107.7K |
| Mar 6, 2026 | Kaitlin M. Kestenberg-Messina | Other F | 10.1K | $154.8K |
| Mar 6, 2026 | Adam S Grossman KEY | Other F | 56.4K | $868.6K |
| Mar 5, 2026 | Steve Elms | Buy P | 7.0K | $109.7K |
| Feb 26, 2026 | Adam S Grossman KEY | Other F | 54.9K | $832.7K |
| Feb 19, 2026 | Kaitlin M. Kestenberg-Messina | Other F | 8.2K | $133.2K |
| Feb 19, 2026 | Adam S Grossman KEY | Other F | 24.8K | $404.6K |
| Feb 19, 2026 | Brad L. Tade KEY | Other F | 6.5K | $105.7K |
| Feb 17, 2026 | Adam S Grossman KEY 10b5-1 | Exercise M | 15.0K | $0 |
| Feb 17, 2026 | Adam S Grossman KEY 10b5-1 | Sell S | 6.0K | $96.5K |
| Feb 17, 2026 | Adam S Grossman KEY 10b5-1 | Sell S | 15.0K | $241.2K |
| Feb 17, 2026 | Adam S Grossman KEY 10b5-1 | Exercise M | 15.0K | $81.0K |
| Feb 9, 2026 | Jerrold B Grossman | Grant A | 17.7K | $0 |
| Feb 9, 2026 | Jerrold B Grossman | Grant A | 10.7K | $0 |
| Feb 9, 2026 | Kaitlin M. Kestenberg-Messina | Grant A | 144.2K | $0 |
| Feb 9, 2026 | Kaitlin M. Kestenberg-Messina | Grant A | 91.6K | $0 |
| Feb 9, 2026 | Adam S Grossman KEY | Grant A | 444.7K | $0 |
| Feb 9, 2026 | Adam S Grossman KEY | Grant A | 282.5K | $0 |
| Feb 9, 2026 | Young Kwon | Grant A | 17.7K | $0 |
| Feb 9, 2026 | Young Kwon | Grant A | 10.7K | $0 |
| Feb 9, 2026 | Alison Cecily Finger | Grant A | 17.7K | $0 |
| Feb 9, 2026 | Alison Cecily Finger | Grant A | 10.7K | $0 |
| Feb 9, 2026 | Eduardo Rene Salas | Grant A | 17.7K | $0 |
| Feb 9, 2026 | Eduardo Rene Salas | Grant A | 10.7K | $0 |
| Feb 9, 2026 | Lawrence P. Guiheen | Grant A | 17.7K | $0 |
| Feb 9, 2026 | Lawrence P. Guiheen | Grant A | 10.7K | $0 |
| Feb 9, 2026 | Steve Elms | Grant A | 17.7K | $0 |
| Feb 9, 2026 | Steve Elms | Grant A | 10.7K | $0 |
About ADMA insider trading
This page tracks insider transactions for ADMA BIOLOGICS, INC. (ADMA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.